OncoCare Monolitik is a system with multiple modules on which drugs are prepared quickly and simultaneously in Class 2B2 standards.
Fully-Automated
Chemotherapy Drug Compounding Systems
01. System with Multiple Modules
Oncocare Monolitik is a system with multiple modules on which drugs are prepared quickly and simultaneously in Class 2B2 standards.
02. High Sensitivity
Correct doses are achieved with high sensitivity volumetric filling and gravimetric validation.
03. Prefilling System
Before drug preparation, bags can be filled with dilutive solutions with the prefilling system.
04. Monitor & Control Drug Preparation
Each module has its control screen to monitor and control the drug preparation process.
Monolitik Full Automatic Drug Preparation Device with 2-Station
05. Specific Clinical Software
Recording and monitoring of prepared drugs can be done with chemotherapy-specific clinical software.
06. Cross-Contamination
Separator glasses are used between modules in order to prevent cross-contamination.
07. Waste System
Users are protected from a toxic environment with air circulation and a fully automated waste system which is controlled with hand sensors.
07. QR Code System
Possible user mistakes of drugs and supplies are prevented with QR code system.
OncoCare Monolitik Highlights
Design
User Friendly
Superior Validation
Adaptive
Security
Economy
Design
- ABS tactile chassis
- Waste management system specific to each station
- Separate work areas
User Friendly
- Negative Pressure
- Class2 – B2 cabin.
- Operator safety.
- User-friendly Interface.
- 11” screen. (Independent stations)
- Fully safe waste management system
Superior Validation
- Gravemetric verification.
- Volumetric verification.
- 0.1 ml precision
Adaptive
- Compatible with 5-10-20 50 ml injectors
- Fast Pre-fill
- Various bag filling.
- Patient order entry – drug prepared with barcode
Security
- Fully automatic filling.
- Patient follow-up. (can be monitored)
- Barcode and image matching technology.
- Full protection waste storage system
Economy
- Increased drug monitoring. Zero drug losses.
- Traceable consumables.
- Low investment cost
OncoCare Monolitik
Fully-Automated Chemotherapy Drug Compounding Systems
